Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DaVita Inc V.DVA


Primary Symbol: DVA

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.


NYSE:DVA - Post by User

Post by Voteliberalon Jul 17, 2017 11:45pm
70 Views
Post# 26479610

1.5g individual sachets

1.5g individual sachetsPurchased 10 x 1.5g individual sachets Healing cream. Very nice packaging. Plus there was an extra Sachet of 1 x pain relief, and 1 x nerve pain relief cream. 

January 24, 2017 – Toronto, Ontario – Delivra Corp. (TSXV: DVA – “Delivra” or the “Company”) subsidiary LivCorp Inc. announced today a new distribution agreement with Spike Marks Inc. (“Spike”) for the launch of its three Over-the-Counter products in a simple and revolutionary single dose travel size.

 

With this agreement, consumers will see new 1.5g single-use sachets of the rapidly growing LivRelief Pain Relief Cream, LivRelief Nerve Pain Cream and LivRelief Healing Cream available in convenience stores throughout Canada. This will add to the LivRelief successful brand awareness strategy for both its natural and pharmaceutical products.

“Spike offers unparalleled access to the Canadian market, providing comprehensive and consistently outstanding service to more than 27,000 points of sale from Vancouver Island to Newfoundland. This expanded availability and distribution, give consumers a new way to sample our products,” commented Dr. Joseph Gabriele, Delivra’s Chief Executive Officer. In addition, this revolutionary packaging system will be used for Delivra’s future pharmaceutical products to prevent overdosing. Delivra aims to increase brand awareness and drive sales of its larger sized products currently available in pharmacies and retail chains across the country. “

Delivra’s suite of topical creams under the “LivRelief” brand has been available in retail stores since 2012. The new, convenient single-use packages will begin to make their way into point of purchase displays. The 25-pack displays will make their way into as many as 500 retail locations in Canada, beginning February, 2017. The patented Easysnap packaging provides hygienic, clean ease of use for added convenience. Delivra’s suite of products utilizes the transdermal delivery technology developed by Dr. Joseph Gabriele and his team at Delivra. Delivra uses the innovative transdermal delivery system to deliver target relief using natural ingredients. LivRelief products provide targeted opioid-free pain relief alternatives to millions of Canadians.

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse